STRATA Skin Sciences (SSKN) Stock Price, News & Analysis

Company Overview

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Key Stats

• Today's Range: $2.88 to $3.11
• 50-Day Range: $2.87 to $3.34
• 52-Week Range: $2.51 to $6.00
• Volume: 12,212 shs
• Average Volume: 5,083 shs
• Market Capitalization: $12.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

STRATA Skin Sciences Stock Analysis - MarketRank™

STRATA Skin Sciences scored higher than 28% of companies evaluated by MarketBeat, and ranked 650th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for STRATA Skin Sciences.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for STRATA Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of STRATA Skin Sciences is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of STRATA Skin Sciences is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

STRATA Skin Sciences has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.18% of the float of STRATA Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

STRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STRATA Skin Sciences has recently decreased by 16.67%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

STRATA Skin Sciences does not currently pay a dividend.

Dividend Growth

STRATA Skin Sciences does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.18% of the float of STRATA Skin Sciences has been sold short.

Short Interest Ratio / Days to Cover

STRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in STRATA Skin Sciences has recently decreased by 16.67%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for SSKN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

1 people have added STRATA Skin Sciences to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.00% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 32.43% of the stock of STRATA Skin Sciences is held by institutions.

SSKN Stock Analysis - Frequently Asked Questions

How have SSKN shares performed this year?

STRATA Skin Sciences' stock was trading at $2.91 at the beginning of 2025. Since then, SSKN stock has decreased by 0.2% and is now trading at $2.9050.
View the best growth stocks for 2025 here.

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) posted its quarterly earnings results on Friday, March, 31st. The medical device company reported ($0.50) earnings per share (EPS) for the quarter. The medical device company earned $10.60 million during the quarter. STRATA Skin Sciences had a negative net margin of 28.72% and a negative trailing twelve-month return on equity of 69.33%.

When did STRATA Skin Sciences' stock split?

STRATA Skin Sciences's stock reverse split before market open on Friday, June 7th 2024. The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that STRATA Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 3/31/2023
• Today: 1/21/2025
• Next Earnings (Estimated): 3/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SSKN
• CUSIP: N/A
• CIK: 1051514
• Web: www.strataskinsciences.com
• Phone: (215) 619-3200
• Fax: 215-619-3208
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.66)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-10,830,000.00
• Net Margins: -28.72%
• Pretax Margin: -29.00%
• Return on Equity: -69.33%
• Return on Assets: -17.55%

Debt

• Debt-to-Equity Ratio: 1.62
• Current Ratio: 1.13
• Quick Ratio: 0.94

Sales & Book Value

• Annual Sales: $33.36 million
• Price / Sales: 0.37
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.65 per share
• Price / Book: 0.81

Miscellaneous

• Outstanding Shares: 4,170,000
• Free Float: 2,544,000
• Market Cap: $12.28 million
• Optionable: Not Optionable
• Beta: 1.34